Nikita Jinna

11PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer geneticsFeminist methodologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 12, 2026
Racial Disparity in Ductal Carcinoma in Situ: Risk-Predictive and Actionable Biomarkers for Early Intervention.

|Mar 28, 2026
Margin of Error: The Emerging Role of Field Cancerization in Predicting Recurrence Risk of Ductal Carcinoma In Situ.

Sophia Hu-Lieskovan, Olivia Banks, Rose Davidson

|Feb 27, 2026
FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer.

Padmashree Rida, Raphael Andreae, Noah Bikhazi

|Mar 28, 2025
Mixed-Methods Approach: Impact of Clinical Consenter Diversity on Clinical Trials Enrollment.

Angelica Sanchez, Christina M Vidal, Noé Rubén Chávez

|Sep 28, 2024
FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer.

Padmashree Rida, Sophia Baker, Adam Saidykhan

|Nov 25, 2023
Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.

Nikita Jinna, Yate-Ching Yuan, Padmashree Rida

Pageof 2

Frequent Collaborators

3 joint publications

Tijana Jovanovic-Talisman

3 joint publications

Rama Natarajan

1 joint publications

Christopher Sistrunk

1 joint publications

Christine Ambrosone